PAREXEL International Corp. has expanded its evidence-based services for biopharmaceutical products with PAREXEL Access, which focuses on clinical research and operations, market access consulting, medical communications, and pharmacovigilance to help companies identify, evaluate, generate evidence of product value needed for market access and to support product lifecycle.   With the cost and time involved in developing and gaining marketing approval of a new drug, increasingly the transition ...